NDAINHALATIONGAS
Approved
Mar 2014
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
3/8 — Basic
Drug data last refreshed Yesterday · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
HELIUM, USP is an inhaled gas product approved by the FDA in March 2014 as a treatment modality delivered via inhalation. The product is a respiratory gas with minimal pharmacologic mechanism of action documented in standard references. Patient populations receiving this therapy typically have respiratory compromise requiring gas-based interventions.
Peak
Peak lifecycle status indicates mature market presence with stable commercial infrastructure; team size and growth potential are moderate.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
Evaluate the Safety and Feasibility of Same-Day Bilateral Epithelium-On Corneal Cross-Linking for Keratoconus
Started May 2026
15 enrolled
Keratoconus
Establishment of Biobank of Nasal Epithelium Samples From Healthy Volunteers
Started Nov 2023
120 enrolled
Healthy
Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age with Keratoconus
Started Nov 2023
400 enrolled
Keratoconus
Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus
Started Oct 2023
400 enrolled
Keratoconus
C2 Esophageal Squamous Epithelium Dysplasia
Started Nov 2022
129 enrolled
Esophageal Squamous Epithelium Dysplasia
Worked on HELIUM, USP at Advanced Solutions Life Sciences? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.